FDA Clearance Tracker · K170132
MyoCycle Home, MyoCycle Pro
Last checked: Nov 20, 2026Latest source record: Apr 25, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Apr 25, 2017
Substantially Equivalent
Time to decision
98 days
Received Jan 17, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K170132
- Device name
- MyoCycle Home, MyoCycle Pro
- Applicant
- Myolyn, LLC
- Applicant location
- Gainesville, FL
- Received
- Jan 17, 2017
- Decided
- Apr 25, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5810
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GZI. The earliest in FDA's data is K770725, decided Apr 26, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K170132
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Myolyn, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K213925 · Decided Apr 25, 2022 · 130 days after receipt
Device type: Stimulator, Neuromuscular, External Functional (GZI) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.